Compare AdaptHealth Corp (AHCO) vs GE Aerospace (GE) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

GE Aerospace stock trades at $356.03, down 5.98% on the day, but maintains strong fundamental momentum with three consecutive quarterly earnings beats (Q3 2025-Q1 2026). Revenue grew to $45.86B in 2025, with net income margin reaching 18.98%. Technical indicators show a bullish moving average trend, while oscillators are neutral. The company benefits from robust aerospace demand, a large backlog, and recent defense contract wins, supporting a positive outlook despite a high P/E ratio of 45.59.

The outlook for GE remains favorable, driven by strong order growth and strategic investments in MRO and manufacturing. Risks include elevated valuation metrics, rising costs, and high debt levels. Analyst consensus is strongly bullish with a $394.33 price target, implying ~11% upside. Continued execution on defense and commercial engine contracts is key to sustaining growth momentum.